Target intelligence / Profile preview

A-kinase anchoring protein 8 (AKAP8)

Target
AKAP8
Molecular classification
Scaffolding protein, RNA-binding protein, DNA-binding protein, Chromatin-associated protein
01

Overview

A-kinase anchoring protein 8 (AKAP8) is a multifunctional nuclear scaffold protein that coordinates several regulatory complexes and processes in the nucleus. It anchors protein kinase A (PKA) and creates spatial microdomains for cAMP-dependent signaling, regulates chromatin architecture by mediating interactions with chromatin-modifying enzymes, and acts directly in the control of gene expression, DNA replication, and mitosis through association with the nuclear matrix and chromatin structures[1][2][3]. As an RNA-binding protein, AKAP8 modulates alternative pre-mRNA splicing events pivotal for maintaining epithelial identity and inhibiting epithelial-mesenchymal transition (EMT), thus suppressing tumor metastasis[2][4]. It also partners with mitotic and chromatin factors such as MCM2 and HDAC3, playing roles in epigenetic regulation and cell cycle progression[2][3]. In cancer, high AKAP8 expression is associated with better prognosis, particularly in breast cancer, where it acts to inhibit EMT and metastasis by regulating alternative splicing of specific transcripts[4]. The function and localization of AKAP8 are modulated by post-translational modifications, including tyrosine phosphorylation by nuclear kinases, leading to changes in chromatin association and gene regulatory activities[1].

Other names
A-kinase anchor protein 8AKAP95AKAP-8A-kinase anchor protein 95 kDaDKFZp586B1222A kinase (PRKA) anchor protein 8
02

Biological functions

Nuclear scaffoldingChromatin structural regulationRegulation of gene expressionPre-mRNA splicingCell cycle controlDNA replicationMitotic progressionEpigenetic modificationApoptosis regulationcAMP signaling organization
03

Disease associations

Cancer (tumor metastasis suppression, breast cancer prognosis)Cell identity maintenanceEpigenetic dysregulation
04

Safety considerations

Loss of AKAP8 may promote epithelial-mesenchymal transition (EMT) and cancer metastasis[4]No significant safety concerns for pharmacological targeting have been described
05

Biomarkers

AKAP8 and its splicing targets (e.g., CLSTN1 mRNA isoforms) as prognostic indicators in cancer, especially breast cancer[4]

Beyond the preview

Go deeper on A-kinase anchoring protein 8 (AKAP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-kinase anchoring protein 8 (AKAP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call